Skip to content
Screener

Teladoc Health TDOC Q2 2026 earnings

Reported July 29, 2026 · After market close

Revenue$606.9MMiss by $8.5M
EPS-$0.21Beat by $0.04
Revenue estimate$615.4M
EPS estimate-$0.25
“We delivered solid Integrated Care segment performance, with revenue growth and adjusted EBITDA margin above the midpoint of our guidance ranges and continued to advance new innovations designed to strengthen the value we provide to clients and members, including the launch of Teladoc One, our new connected care model for the U.S. market.”
Chuck Divita

Next report

Oct 28, 2026 (in a month)
Revenue estimate$590.3M
EPS estimate-$0.23

Financials

Q2 2026

Income statement

See full
Revenue$606.9M-4.0%
Gross profit$416.1M-5.7%
Operating income-$37.1M+31.8%
Net income-$38.9M-19.1%
EPS (diluted)-$0.21-10.5%

Balance sheet

See full
Cash & equivalents$774.3M+13.9%
Total debt$1.0B+2,371%
Total equity$1.3B-7.9%
Total assets$2.8B-4.7%

Cash flow

See full
Operating cash flow$64.7M-29.3%
CapEx$928.0K-26.8%
Free cash flow$63.7M-29.3%

Valuation & ratios

Valuation

as of 09/16/26
See full
Market cap$1.2B-14.0%
Enterprise value$1.46B+93.6%
P/S0.5×-0.1×

Profitability

See full
Gross margin69%-1.3pp
Operating margin-7.5%-1.7pp
Net margin-7.1%-0.8pp
FCF margin10.2%-1.3pp

Returns & leverage

See full
Return on equity-13%-1.0pp
Debt / equity0.8×+0.8×
Current ratio0.8×-1.8×

Segments

By segment

See full
Integrated Care$394.3M+0.7%
BetterHelp$212.6M-11.6%

By product

See full
Access Fees$474.2M-9.4%
Other$132.7M+22.7%

By geography

See full
United States$487.4M—

FAQ

When did Teladoc Health report Q2 2026 earnings?
Teladoc Health (TDOC) reported Q2 2026 earnings on July 29, 2026 after market close.
What were Teladoc Health's Q2 2026 revenue and EPS?
Teladoc Health reported revenue of $606.9M and eps of $-0.21 for Q2 2026.
Did Teladoc Health beat estimates in Q2 2026?
Revenue missed the consensus estimate of $615.4M by $8.5M. EPS beat the consensus estimate of $-0.25 by $0.04.
How did Teladoc Health's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 4.0% from $631.9M a year earlier and eps declined 10.5% from $-0.19.
Where can I find Teladoc Health's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001477449-26-000036) and the 10-Q periodic report (0001477449-26-000038) directly on SEC EDGAR. The filing index links above go to sec.gov.